Skip to content
Riskpilot
← Back to search
Sign in
Get full access
URSAPHARM NORDIC AB
AB
Active
Org 5594607581
Kungsgatan 1, 702 11
Örebro
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2023
5-9 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
URSAPHARM NORDIC AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
10M
20M
29M
39M
34M
2024
EBITDA
SEK millions
0M
2M
3M
5M
7M
6M
2024
Income statement
SEK thousands
Item
2024
Revenue
33 850
Staff expenses
—
EBITDA
6 289
Depreciation & amort.
−33
EBIT
6 256
Net financials
−172
Profit before tax
6 084
Tax
−1 270
Net profit
4 814
Balance sheet
SEK thousands
Item
2024
Total assets
47 950
Equity
4 839
Long-term debt
5 628
Short-term debt
37 483
Total debt
43 111
Financial ratios
5-year trend
EBITDA margin
18.6%
This company
15.8%
Market median
+18% vs market
2024
2024
Equity ratio
10.1%
This company
38.2%
Market median
-74% vs market
2024
2024
Return on equity
99.5%
This company
18.4%
Market median
+441% vs market
2024
2024
Net profit margin
14.2%
This company
8.1%
Market median
+75% vs market
2024
2024
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
2024
2024
Debt / equity
8.91×
This company
0.62×
Market median
-1337% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-12-31
View
PDF
More on URSAPHARM NORDIC AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
